NVOS
Price:
$0.037
Market Cap:
$705.02K
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services, and Product Manufacturing and Development. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, s...[Read more]
Industry
Medical - Care Facilities
IPO Date
2021-02-23
Stock Exchange
NASDAQ
Ticker
NVOS
According to Novo Integrated Sciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -137.80%. This represents a change of 223.77% compared to the average of -42.56% of the last 4 quarters.
The mean historical ROE of Novo Integrated Sciences, Inc. over the last ten years is -2047.59%. The current -137.80% ROE has changed -93.27% with respect to the historical average. Over the past ten years (40 quarters), NVOS's ROE was at its highest in in the March 2015 quarter at 3.25%. The ROE was at its lowest in in the February 2018 quarter at -363.03%.
Average
-2047.59%
Median
-80.77%
Minimum
-18780.68%
Maximum
17.30%
Discovering the peaks and valleys of Novo Integrated Sciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.35%
Maximum Annual ROE = 17.30%
Minimum Annual Increase = -11469.27%
Minimum Annual ROE = -18780.68%
Year | ROE | Change |
---|---|---|
2024 | -108.30% | 103.38% |
2023 | -53.25% | -63.84% |
2022 | -147.27% | 1.35% |
2021 | -10.17% | -38.69% |
2020 | -16.59% | 983.00% |
2019 | -1.53% | -99.85% |
2018 | -1046.73% | -6149.78% |
2017 | 17.30% | -105.26% |
2016 | -328.64% | -98.25% |
2015 | -18780.68% | -11469.27% |
The current ROE of Novo Integrated Sciences, Inc. (NVOS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-102.94%
5-year avg
-67.12%
10-year avg
-2047.59%
Novo Integrated Sciences, Inc.’s ROE is less than IMAC Holdings, Inc. (756.40%), less than Assure Holdings Corp. (139.91%), less than Aveanna Healthcare Holdings Inc. (48.79%), greater than P3 Health Partners Inc. (-71.31%), less than IMAC Holdings, Inc. (756.40%), greater than The Oncology Institute, Inc. (-176.71%), greater than Cano Health, Inc. (-3260.92%), greater than LifeStance Health Group, Inc. (-6.66%), greater than agilon health, inc. (-50.48%), less than The Pennant Group, Inc. (13.81%), less than Community Health Systems, Inc. (26.17%), greater than Brookdale Senior Living Inc. (-59.31%), less than Universal Health Services, Inc. (16.10%), less than Tenet Healthcare Corporation (101.08%), less than DaVita Inc. (110.29%), less than AMN Healthcare Services, Inc. (6.14%), less than Acadia Healthcare Company, Inc. (9.65%),
Company | ROE | Market cap |
---|---|---|
756.40% | $1.74M | |
139.91% | $141.03K | |
48.79% | $854.05M | |
-71.31% | $65.66M | |
756.40% | $2.44M | |
-176.71% | $16.88M | |
-3260.92% | $12.43M | |
-6.66% | $2.79B | |
-50.48% | $786.95M | |
13.81% | $925.35M | |
26.17% | $436.30M | |
-59.31% | $1.01B | |
16.10% | $10.59B | |
101.08% | $12.22B | |
110.29% | $12.71B | |
6.14% | $888.07M | |
9.65% | $3.50B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novo Integrated Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Novo Integrated Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Novo Integrated Sciences, Inc.'s ROE?
How is the ROE calculated for Novo Integrated Sciences, Inc. (NVOS)?
What is the highest ROE for Novo Integrated Sciences, Inc. (NVOS)?
What is the 3-year average ROE for Novo Integrated Sciences, Inc. (NVOS)?
What is the 5-year average ROE for Novo Integrated Sciences, Inc. (NVOS)?
How does the current ROE for Novo Integrated Sciences, Inc. (NVOS) compare to its historical average?